Lane, J Athene <br/><br/>
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.  [electronic resource] 

 -  The Lancet. Oncology  Sep 2014 
 - 1109-18 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(14)70361-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biopsy, Needle<br/>Disease-Free Survival<br/>Follow-Up Studies<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Recurrence, Local--mortality<br/>Patient Selection<br/>Prostate-Specific Antigen--blood<br/>Prostatectomy--methods<br/>Prostatic Neoplasms--mortality<br/>Radiotherapy, Conformal--methods<br/>Risk Assessment<br/>Survival Analysis<br/>Treatment Outcome<br/>United Kingdom<br/>Watchful Waiting--methods